BioSpace News Archive

Syneos Health® announced PM360 has named six distinguished colleagues as recipients of its 10th Annual ELITE 100 Awards.

Lexaria Bioscience Corp., a global innovator in drug delivery platforms announces it has hired a contract research organization to perform the Company’s human pilot study #3, which will evaluate a dual action GLP-1 + GIP.

Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.

On May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma in an oral presentation at the 27th Annual Meeting of the American Society for Gene & Cell Therapy in Baltimore.

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., announced encouraging initial findings from an ongoing Phase 1 clinical trial.

Scientific Industries, Inc. announced it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

Heartbeat Health, the nation’s largest decentralized cardiology provider, and Karoo Health, the only operational provider of cardiac value-based care enablement with published value-based results, announced the formation of a unique value-based enterprise, creating the first national, scalable, end-to-end cardiac value-based care solution for payers, at-risk entities, and provider networks.

Medline announced the latest addition to its respiratory care portfolio, the Hudson RCI TurboMist small volume nebulizer.

Extendicare Inc. announced the results of matters voted on at its annual meeting of shareholders held on May 23, 2024.

Oxurion NV, a biopharmaceutical company headquartered in Leuven, held its annual shareholders’ meeting on May 16, 2024.